Antonio D'avolio

Turin, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 289 publications

Differential pharmacokinetic decay of long-acting cabotegravir and rilpivirine after missed injections: a case series.

Differential pharmacokinetic decay of long-acting cabotegravir and rilpivirine after missed injections: a case series.

Journal: The Journal of antimicrobial chemotherapy

Published: August 11, 2026

Short-Term Pharmacokinetics of Ropivacaine in Arterial Plasma During Erector Spinae Plane Block in Thoracic and Cardiac Surgery.

Short-Term Pharmacokinetics of Ropivacaine in Arterial Plasma During Erector Spinae Plane Block in Thoracic and Cardiac Surgery.

Journal: Pharmaceutics

Published: July 06, 2026

Real-World Evidence: Cefiderocol Therapeutic Drug Monitoring in Critically Ill, Obese Patients with Klebsiella pneumoniae Infections.

Real-World Evidence: Cefiderocol Therapeutic Drug Monitoring in Critically Ill, Obese Patients with Klebsiella pneumoniae Infections.

Journal: Antibiotics (Basel, Switzerland)

Published: May 20, 2026

Precision Redosing of Oritavancin: A Population Pharmacokinetic Framework to Optimize Long-Term Therapy for Complex Gram-Positive Infections.

Precision Redosing of Oritavancin: A Population Pharmacokinetic Framework to Optimize Long-Term Therapy for Complex Gram-Positive Infections.

Journal: International journal of antimicrobial agents

Published: May 13, 2026

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Seminal plasma concentrations of long-acting cabotegravir in men receiving HIV pre-exposure prophylaxis.

Journal: Antimicrobial agents and chemotherapy

Published: April 15, 2026

Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

Oritavancin as consolidation or suppressive therapy in infective endocarditis and device-related infections: real-world experience with therapeutic drug monitoring.

Journal: JAC-antimicrobial resistance

Published: March 20, 2026

Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain.

Reduced-frequency bictegravir, emtricitabine, and tenofovir alafenamide in virologically suppressed adults with HIV: a single-centre randomised phase 2 pilot trial in Spain.

Journal: EClinicalMedicine

Published: March 11, 2026

Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature.

Failure of a LHRH agonist in metastatic prostate cancer: a case report and review of literature.

Journal: Cancer chemotherapy and pharmacology

Published: March 07, 2026

Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study.

Possible Contribution of Oral Microbiota in the Osteonecrosis of the Jaw Induced by Zoledronate or Denosumab: A Preliminary Study.

Journal: Biomedicines

Published: March 04, 2026

UHPLC-MS/MS Method for the Simultaneous Quantification of 12 Antiretroviral Drugs in Human Plasma Using Dried Sample Spot Devices: Development, Validation, and Stability Evaluation.

UHPLC-MS/MS Method for the Simultaneous Quantification of 12 Antiretroviral Drugs in Human Plasma Using Dried Sample Spot Devices: Development, Validation, and Stability Evaluation.

Journal: Pharmaceutics

Published: March 03, 2026

Amoxicillin bone penetration in patients with medication-related osteonecrosis of the jaw: A preliminary study.

Amoxicillin bone penetration in patients with medication-related osteonecrosis of the jaw: A preliminary study.

Journal: International journal of antimicrobial agents

Published: February 23, 2026

An inoperable mediastinal infection involving vascular graft treated with weekly oritavancin as chronic suppressive therapy. A case report with pharmacokinetic data.

An inoperable mediastinal infection involving vascular graft treated with weekly oritavancin as chronic suppressive therapy. A case report with pharmacokinetic data.

Journal: The Journal of antimicrobial chemotherapy

Published: February 17, 2026

Showing 1-12 of 289

Last Updated: 09/26/2026